C-reactive protein (CRP), a well-established systemic inflammatory marker, is strongly associated with tumor CRC progression and recurrence risk, reflecting the inflammatory microenvironment that fosters cancer development and metastasis [9]. This evidence concerns the gene CRP and colorectal carcinoma.